Detail akcie Takeda Pharm online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Takeda Pharmaceutical Co Ltd revenues decreased 3% to Y3.411T. Net income increased 2% to Y216.08B. Revenues reflect Gastrointestinal diseases segment decrease of 29% to Y739.3B, Plasma derivatives segment decrease of 32% to Y529.6B, United States segment decrease of 39% to Y1.127T, Europe And Canada (Country) segment decrease of 28% to Y570.3B.